3-hydroxybutyric acid and fumagillin

3-hydroxybutyric acid has been researched along with fumagillin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hughes, TE; Kim, DD; Marjason, J; Proietto, J; Vath, JE; Whitehead, JP	1

Trials

1 trial(s) available for 3-hydroxybutyric acid and fumagillin

Article	Year
Ascending dose-controlled trial of beloranib, a novel obesity treatment for safety, tolerability, and weight loss in obese women. Obesity (Silver Spring, Md.), 2013, Volume: 21, Issue:9 Topics: 3-Hydroxybutyric Acid; Adiponectin; Aminopeptidases; Anti-Obesity Agents; Aspergillus; Biological Products; Blood Glucose; Blood Pressure; C-Reactive Protein; Cholesterol, LDL; Cyclohexanes; Double-Blind Method; Fatty Acids, Unsaturated; Female; Fibroblast Growth Factors; Glycoproteins; Humans; Hunger; Infusions, Intravenous; Leptin; Lipids; Methionyl Aminopeptidases; Middle Aged; Obesity; Sesquiterpenes; Triglycerides; Weight Loss	2013

Article

Year

Ascending dose-controlled trial of beloranib, a novel obesity treatment for safety, tolerability, and weight loss in obese women.

Obesity (Silver Spring, Md.), 2013, Volume: 21, Issue:9

Topics: 3-Hydroxybutyric Acid; Adiponectin; Aminopeptidases; Anti-Obesity Agents; Aspergillus; Biological Products; Blood Glucose; Blood Pressure; C-Reactive Protein; Cholesterol, LDL; Cyclohexanes; Double-Blind Method; Fatty Acids, Unsaturated; Female; Fibroblast Growth Factors; Glycoproteins; Humans; Hunger; Infusions, Intravenous; Leptin; Lipids; Methionyl Aminopeptidases; Middle Aged; Obesity; Sesquiterpenes; Triglycerides; Weight Loss

2013